Sciele Pharma, Inc., a Shionogi Company, is a pharmaceutical company
specializing in sales, marketing and development of branded prescription
products focused on the therapeutic areas of Cardiovascular, Diabetes,
Women’s Health and Pediatrics. The Company’s Cardiovascular and Diabetes
products treat patients with high cholesterol, hypertension, high
triglycerides, unstable angina and Type 2 diabetes; its Women’s Read the rest of this entry »
Sir Fred ‘the Shred’ Goodwin is a family man who split his high-octane life between the City and his bank’s spanking-new headquarters on the outskirts of Edinburgh.
When working in London he would stay in a suite at the Savoy Hotel (now being refurbished) where his clothes would be looked after by a valet.
A 50-year-old father of two, he is a car enthusiast with a love of Formula One, of which Royal Bank of Scotland has been a long-time sponsor. Read the rest of this entry »
DENVER – The final person who remained hospitalized after an aircraft veered off the runway at Denver International Airport, crashed into a shallow ravine and caught fire more than a week ago has been released from a local hospital.
Erika Matich, spokeswoman for University of Colorado Hospital in Aurora, says they no longer have anyone from the Houston-bound Continental Flight 1404 in their care.
Thirty-eight of 115 people aboard the Boeing 737-500 Read the rest of this entry »
CAPE CANAVERAL, Fla. (AP) — Astronauts carried out one last spacewalk Monday to finish an unprecedented clean and lube job that they began a week ago at the international space station.
Spacewalkers Stephen Bowen and Shane Kimbrough hoped to wrap up work on a jammed solar-wing rotary joint and, as a precaution, squirt some extra grease on another joint that works fine.
Just before Monday’s spacewalk began, NASA added a 16th day to space Read the rest of this entry »
HAWTHORNE, N.Y., Feb 05, 2009 (BUSINESS WIRE) –
— Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets:
) reported today that it has received final approval from the U.S.
Food and Drug Administration (“FDA”) for its Abbreviated New Drug
Application (“ANDA”) for Lamotrigine Tablets (Chewable Dispersible), 5
mg and 25 mg (“lamotrigine chewable tablets”).
Lamotrigine chewable tablets, marketed by GlaxoSmithKline Read the rest of this entry »
IMPAX Laboratories, Inc. (OTC: IPXL)
today confirmed that the
U.S. Food and Drug Administration (FDA) has granted final approval of
the Companys Abbreviated New Drug Application (ANDA) for generic
versions of SOLODYN(R) (minocycline HCI) 45mg, 90mg and 135mg
Extended-release Tablets. Medicis markets SOLODYN(R) for the treatment
of moderate-to-severe acne.
As previously announced on December 1, 2008, IMPAX and Medicis entered
into a Settlement Read the rest of this entry »
Any statements contained in this press release that refer to future events
or other non-historical facts are forward-looking statements that reflect
Watson’s current perspective of existing trends and information as of the date
of this release. Except as expressly required by law, Watson disclaims any
intent or obligation to update these forward-looking statements. Actual
results may differ materially from Watson’s current expectations depending
upon Read the rest of this entry »
GALVESTON — Five emergency room doctors lost their jobs Monday at the University of Texas Medical Branch hospital, part of a purge that will downgrade its trauma center status and contribute to an emergency room shortage in the Houston area, emergency room administrators said.
The cuts came as John Sealy Hospital opened its operating rooms, senior care and pediatric operations for the first time since Hurricane Ike struck Sept. 13. The operating Read the rest of this entry »
CORONA, Calif.
,
Dec. 29
/PRNewswire-FirstCall/ — Watson Pharmaceuticals,
Inc. (NYSE:
), a leader in generic and specialty branded pharmaceuticals,
today announced that its subsidiary, Watson Laboratories, Inc., has received
final approval from the United States Food and Drug Administration on its
Abbreviated New Drug Application (ANDA) for desogestrel/ethinyl estradiol and
ethinyl estradiol tablets, 0.15 mg / 0.02 mg and 0.01 mg and Read the rest of this entry »
An FDA final rule issued Thursday has provided some clarification regarding the sale, purchase and trade of prescription drugs by blood establishments and comprehensive hemophilia diagnostic centers that qualify as health care entities. Under this rule, these establishments will be able to continue their core mission work in several areas that were previously threatened by narrow exclusions to 21 CFR 203 — Prescription Drug Marketing. FDA declined Read the rest of this entry »